P Morice

Summary

Affiliation: Institut Gustave Roussy
Country: France

Publications

  1. ncbi request reprint [New advances in screening and treatment of ovarian cancer]
    Philippe Morice
    Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif
    Bull Cancer 90:53-60. 2003
  2. ncbi request reprint Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications
    Philippe Morice
    Department of Surgery, Institut Gustave Roussy, Villejuif, France
    J Am Coll Surg 197:198-205. 2003
  3. ncbi request reprint A need for laparoscopic evaluation of patients with endometrial carcinoma selected for conservative treatment
    Philippe Morice
    Service de Chirurgie Gynecologique, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
    Gynecol Oncol 96:245-8. 2005
  4. doi request reprint Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence
    Philippe Morice
    Department of Gynaecological Surgery, Institut Gustave Roussy, Villejuif, France
    Lancet Oncol 13:e103-15. 2012
  5. doi request reprint Gynaecological cancers in pregnancy
    Philippe Morice
    Department of Gynecologic Surgery, Institut Gustave Roussy, Villejuif, France
    Lancet 379:558-69. 2012
  6. ncbi request reprint Port-site metastasis after laparoscopic surgery for gynecologic cancer. A report of six cases
    P Morice
    Department of Gynecologic Surgery, Institut Gustave Roussy, Villejuif, France
    J Reprod Med 45:837-40. 2000
  7. ncbi request reprint Retroperitoneal drainage after complete Para-aortic lymphadenectomy for gynecologic cancer: a randomized trial
    P Morice
    Department of Gynecologic Surgery, Imaging, Oncology and Radiotherapy, Institut Gustave Roussy, Villejuif, France
    Obstet Gynecol 97:243-7. 2001
  8. ncbi request reprint Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer
    P Morice
    Department of Gynecologic Surgery, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805, Villejuif, France
    Eur J Cancer 37:985-90. 2001
  9. ncbi request reprint Late intracaval and intracardiac leiomyomatosis following hysterectomy for benign myomas treated by surgery and GnRH agonist
    P Morice
    Department of Gynecologic Surgery, Institut Gustave Roussy, Villejuif Cedex, 94805, France
    Gynecol Oncol 83:422-3. 2001
  10. ncbi request reprint Results of conservative treatment in epithelial ovarian carcinoma
    P Morice
    Department of Surgery, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
    Cancer 92:2412-8. 2001

Collaborators

Detail Information

Publications138 found, 100 shown here

  1. ncbi request reprint [New advances in screening and treatment of ovarian cancer]
    Philippe Morice
    Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif
    Bull Cancer 90:53-60. 2003
    ..Advances in chemotherapy and new drugs will be also studied in this paper...
  2. ncbi request reprint Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications
    Philippe Morice
    Department of Surgery, Institut Gustave Roussy, Villejuif, France
    J Am Coll Surg 197:198-205. 2003
    ..The purpose was to determine the factors influencing nodal involvement and topography of pelvic and paraaortic node involvement in ovarian carcinoma...
  3. ncbi request reprint A need for laparoscopic evaluation of patients with endometrial carcinoma selected for conservative treatment
    Philippe Morice
    Service de Chirurgie Gynecologique, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
    Gynecol Oncol 96:245-8. 2005
    ..The aim of this paper was to report two cases of extrauterine disease in patients with early stage endometrial cancer (EC) who desired fertility-sparing management...
  4. doi request reprint Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence
    Philippe Morice
    Department of Gynaecological Surgery, Institut Gustave Roussy, Villejuif, France
    Lancet Oncol 13:e103-15. 2012
    ....
  5. doi request reprint Gynaecological cancers in pregnancy
    Philippe Morice
    Department of Gynecologic Surgery, Institut Gustave Roussy, Villejuif, France
    Lancet 379:558-69. 2012
    ..In patients with peritoneal spread or high-risk early-stage disease, neoadjuvant chemotherapy with pregnancy preservation could be appropriate...
  6. ncbi request reprint Port-site metastasis after laparoscopic surgery for gynecologic cancer. A report of six cases
    P Morice
    Department of Gynecologic Surgery, Institut Gustave Roussy, Villejuif, France
    J Reprod Med 45:837-40. 2000
    ..Port-site metastasis after laparoscopic surgery for gynecologic cancer is a recognized entity...
  7. ncbi request reprint Retroperitoneal drainage after complete Para-aortic lymphadenectomy for gynecologic cancer: a randomized trial
    P Morice
    Department of Gynecologic Surgery, Imaging, Oncology and Radiotherapy, Institut Gustave Roussy, Villejuif, France
    Obstet Gynecol 97:243-7. 2001
    ..To determine the relationship between retroperitoneal drainage after complete para-aortic lymphadenectomy for gynecologic cancer and subsequent development of lymphocysts...
  8. ncbi request reprint Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer
    P Morice
    Department of Gynecologic Surgery, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805, Villejuif, France
    Eur J Cancer 37:985-90. 2001
    ..Approximately two-thirds of this cost was due to systematic examinations (Pap smears and radiography). Our results indicate that such expenditure could be avoided...
  9. ncbi request reprint Late intracaval and intracardiac leiomyomatosis following hysterectomy for benign myomas treated by surgery and GnRH agonist
    P Morice
    Department of Gynecologic Surgery, Institut Gustave Roussy, Villejuif Cedex, 94805, France
    Gynecol Oncol 83:422-3. 2001
    ..The aim of this study was to report an exceptional case of a patient presenting with intracaval and intracardiac leiomyomatosis treated by combined surgical and medical treatment...
  10. ncbi request reprint Results of conservative treatment in epithelial ovarian carcinoma
    P Morice
    Department of Surgery, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
    Cancer 92:2412-8. 2001
    ..The objective of this study was to assess and evaluate the clinical outcome and fertility in patients treated conservatively for epithelial ovarian carcinoma (EOC)...
  11. ncbi request reprint [Results and fertility after conservative treatment of invasive epithelial ovarian cancer]
    P Morice
    Service de chirurgie oncologique gynécologique, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France
    Gynecol Obstet Fertil 30:684-91. 2002
    ..The aim of this study is to assess the clinical outcome and fertility in patients managed conservatively for epithelial ovarian cancer (EOC)...
  12. ncbi request reprint [Prognostic factors and treatment for advanced-stage borderline ovarian tumors]
    P Morice
    Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif Cedex, France
    J Gynecol Obstet Biol Reprod (Paris) 31:623-8. 2002
    ..The aim of this review is to study the incidence, the prognostic factors and the treatment of patients with advanced stage borderline ovarian tumor (BOT) associated with extra-ovarian disease (peritoneal implants and/or nodal disorders)...
  13. ncbi request reprint Results of interval debulking surgery in advanced stage ovarian cancer: an exposed-non-exposed study
    P Morice
    Department of Surgery, Institut Gustave Roussy, Villejuif, France
    Ann Oncol 14:74-7. 2003
    ..To study the results of interval debulking surgery (IDS) in patients treated for 'unresectable' advanced stage ovarian cancer compared with primary debulking surgery (PDS) followed by chemotherapy...
  14. ncbi request reprint Prognostic factors for patients with advanced stage serous borderline tumours of the ovary
    P Morice
    Department of Surgery, Institut Gustave Roussy, Villejuif, France
    Ann Oncol 14:592-8. 2003
    ..The aim of this study was to determine the prognostic factors for patients with advanced stage, low malignant potential ovarian tumour (LMPOT)...
  15. ncbi request reprint [Surgery for uterine sarcoma: review of the literature and recommendations for the standard surgical procedure]
    P Morice
    Service de chirurgie oncologique gynécologique, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805, Villejuif, France
    Gynecol Obstet Fertil 31:147-50. 2003
    ..Surgical resection should be ideally performed without uterine parcelling out and so using a laparotomy in order to avoid this risk...
  16. ncbi request reprint Results of conservative management of epithelial malignant and borderline ovarian tumours
    Philippe Morice
    Department of Gynecologic Surgery, Institut Gustave Roussy, Villejuif, France
    Hum Reprod Update 9:185-92. 2003
    ..Removal of the preserved ovary should be carried out after completion of pregnancy(ies) in order to reduce the risk of ovarian tumour recurrence...
  17. ncbi request reprint Prognostic value of lymphovascular space invasion determined with hematoxylin-eosin staining in early stage cervical carcinoma: results of a multivariate analysis
    P Morice
    Department of Surgery, Institut Gustave Roussy, Villejuif, France
    Ann Oncol 14:1511-7. 2003
    ..Our aim was to study the prognostic value of the presence of lymphovascular space invasion (LVSI) in patients with stage IB and II cervical carcinoma treated by initial surgery...
  18. ncbi request reprint [Modalities and limits of conservative treatment of adenocarcinoma in situ of the uterine cervix: analysis of nine cases and review of the literature]
    S Omnes
    Service de chirurgie oncologique gynécologique, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France
    Gynecol Obstet Fertil 31:912-9. 2003
    ..The aim of this study is to assess the results of conservative management of adenocarcinoma in situ (AIS) of the uterine cervix in young patients...
  19. ncbi request reprint Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery-radiation therapy
    P Morice
    Department of Gynecologic Surgery, Institut Gustave Roussy, Villejuif, France
    Ann Oncol 15:218-23. 2004
    ..The aim of this study was to determine the value of routine follow-up for the detection of recurrence in patients treated for cervical cancer...
  20. ncbi request reprint First case of a centropelvic recurrence after radical trachelectomy: literature review and implications for the preoperative selection of patients
    Philippe Morice
    Department of Gynecologic Surgery, Institut Gustave Roussy, Villejuif, France
    Gynecol Oncol 92:1002-5. 2004
    ..To report the first case of a centropelvic recurrence in a patient who underwent a radical trachelectomy (RT) for a stage IB1 cervical carcinoma...
  21. ncbi request reprint Surgical procedure in patients with ovarian cancer diagnosed at the time of prophylactic oophorectomy. Analysis of two cases, literature review and surgical implications
    P Morice
    Institut Gustave Roussy, 39 rue Camlle Desmoulins, Villejuif Cedex 94805, France
    Eur J Obstet Gynecol Reprod Biol 113:251-4. 2004
    ..5 years of follow-up after the end of adjuvant treatment. In order to ensure the exact spread of the disease. Lymphadenectomy should be performed in patients with ovarian cancer diagnosed at the time of prophylactic surgery...
  22. ncbi request reprint Port-site implantation after laparoscopic treatment of borderline ovarian tumors
    Philippe Morice
    Institut Gustave Roussy, Villejuif, France
    Obstet Gynecol 104:1167-70. 2004
    ..The aim of this article is to report 3 cases of port-site implantation after laparoscopic treatment of a borderline ovarian tumor...
  23. ncbi request reprint [Management of advanced stage ovarian cancer]
    Philippe Morice
    Institut Gustave Roussy, 94905 Villejuif
    Rev Prat 54:1777-86. 2004
    ..This treatment is actually studied in randomized trials...
  24. ncbi request reprint Advances in the surgical management of invasive cervical cancer
    Philippe Morice
    Institut Gustave Roussy, Villejuif, France
    Curr Opin Obstet Gynecol 17:5-12. 2005
    ..Surgery plays a major role, particularly in patients with early-stage disease. This review focuses on the evaluation of important papers published since January 2003 on the management of invasive cervical cancer...
  25. ncbi request reprint [Initial or interval debulking surgery for advanced stage ovarian cancer: state-of-the-art. How to select patients?]
    P Morice
    Service de Chirurgie, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif Cedex, France
    Gynecol Obstet Fertil 33:55-63. 2005
    ..But criteria to select patients between initial and interval debulking surgery should be clearly defined. Those different points will be studied in this paper...
  26. ncbi request reprint Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d'Oncologie Gynécologique)
    Philippe Morice
    Institut Gustave Roussy, Villejuif, France
    Hum Reprod 20:1379-85. 2005
    ..The aim of this study was to assess the clinical outcomes and fertility following fertility-sparing surgical management of EOC in a retrospective multicentre study...
  27. ncbi request reprint Borderline tumours of the ovary and fertility
    P Morice
    Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
    Eur J Cancer 42:149-58. 2006
    ..The rate of recurrence is increased but without any impact on survival...
  28. ncbi request reprint The role of surgery after chemoradiation therapy and brachytherapy for stage IB2/II cervical cancer
    P Morice
    Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
    Gynecol Oncol 107:S122-4. 2007
    ..The aim of this study was to review the results of completion surgery after chemoradiation therapy in stage IB2/II cervical carcinoma...
  29. ncbi request reprint Therapy Insight: fertility in women after cancer treatment
    Philippe Morice
    Gynecologic Surgery, Institut Gustave Roussy, Villejuif, France
    Nat Clin Pract Endocrinol Metab 3:819-26. 2007
    ....
  30. doi request reprint French recommendations on the management of invasive cervical cancer during pregnancy
    Philippe Morice
    Department of Surgery, Institut Gustave Roussy, Villejuif, France
    Int J Gynecol Cancer 19:1638-41. 2009
    ..A Working Group was set up in 2007 in France to propose national recommendations for the management of pregnant patients with invasive cervical carcinoma...
  31. doi request reprint Recommendations of the Fertility Task Force of the European Society of Gynecologic Oncology about the conservative management of ovarian malignant tumors
    Philippe Morice
    ESGO Task Force for Fertility Preservation in Gynecological Cancer, Geneva, Switzerland
    Int J Gynecol Cancer 21:951-63. 2011
    ..In patients with nonepithelial malignant ovarian tumors, conservative surgery is also feasible, particularly in patients with malignant germ cell tumors because of their high chemosensitivity leading to an excellent prognosis in general...
  32. pmc Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer
    Philippe Morice
    Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
    Oncologist 17:64-71. 2012
    ..Nevertheless, some of them discuss completion surgery (hysterectomy [HT]) after CRT. The aim of this study was to investigate the therapeutic impact of such surgery...
  33. ncbi request reprint Prognosis of stage III or IV primary peritoneal serous papillary carcinoma
    G Dubernard
    Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
    Eur J Surg Oncol 30:976-81. 2004
    ..To study the prognosis of patients with stage IIIC/IV primary peritoneal serous papillary carcinoma (PSPC) (study group) compared with that of patients with epithelial ovarian carcinoma (EOC) (control group)...
  34. ncbi request reprint Are nodal metastases in ovarian cancer chemoresistant lesions? Analysis of nodal involvement in 105 patients treated with preoperative chemotherapy
    P Morice
    Department of Surgery, Institut Gustave Roussy, Villejuif, France
    Eur J Gynaecol Oncol 25:169-74. 2004
    ..To report the rates of nodal involvement in epithelial ovarian cancer (EOC) in patients who underwent initial lymphadenectomy (before chemotherapy) and patients who underwent lymphadenectomy after chemotherapy...
  35. ncbi request reprint Prognostic value of initial surgical procedure for patients with uterine sarcoma: analysis of 123 patients
    P Morice
    Department of Gynecologic Surgery, Institut Gustave Roussy, Villejuif, France
    Eur J Gynaecol Oncol 24:237-40. 2003
    ..The aim of this series was to study the clinical impact of initial surgical management, particularly of uterine morcellation. on patients treated for uterine sarcoma (US)...
  36. ncbi request reprint Adjuvant chemotherapy with cisplatin, ifosfamide, and doxorubicin followed by radiotherapy in localized uterine sarcomas: results of a case-control study with radiotherapy alone
    P Pautier
    Department of Medical Oncology, Institut Gustave Roussy, Villejuif Cedex, France
    Int J Gynecol Cancer 14:1112-7. 2004
    ..Compared to a case-control study of adjuvant radiotherapy alone, results were not decreased by the addition of a toxic chemotherapy...
  37. ncbi request reprint Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors
    P Pautier
    Departments of Medical Oncology, Institut Gustave Roussy, Villejuif, France
    Int J Gynecol Cancer 18:446-52. 2008
    ..Five patients experienced a low bleomycin pulmonary toxicity. BEP regimen appears to be an active regimen for OGCT in first-line chemotherapy...
  38. doi request reprint [Postoperative morbidity after completion surgery following homogeneous chemoradiation therapy in locally advanced cervical cancer]
    C Touboul
    Département de chirurgie gynécologique, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France
    J Gynecol Obstet Biol Reprod (Paris) 39:624-31. 2010
    ..To evaluate the morbidity rate in patients following completion surgery (hysterectomy±lymphadenectomy) after chemoradiation therapy (CRT) for an advanced stage cervical cancer...
  39. ncbi request reprint Survival in cervix cancer patients treated with radiotherapy followed by radical surgery
    R Rouzier
    Department of Surgical Oncology, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
    Eur J Surg Oncol 31:424-33. 2005
    ....
  40. doi request reprint Impact of adjuvant treatment modalities on the management of patients with stages I-II endometrial stromal sarcoma
    G G Malouf
    Department of Medicine, Institut Gustave Roussy, 39 rue Camille Desmoulins, Villejuif, France
    Ann Oncol 21:2102-6. 2010
    ..The historical options usually discussed in addition to hysterectomy and bilateral salpingoophorectomy (BSO) are active surveillance, pelvic radiotherapy, chemotherapy and hormonal therapy, alone or in combination...
  41. ncbi request reprint [Are nodal metastases in ovarian cancer chemoresistant lesions? Comparative study of initial lymphadenectomy or after chemotherapy]
    F Joulie
    Département de chirurgie oncologique gynécologique, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France
    Gynecol Obstet Fertil 32:502-7. 2004
    ....
  42. doi request reprint Prognostic factors for and prognostic value of mesenteric lymph node involvement in advanced-stage ovarian cancer
    S Gouy
    Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
    Eur J Surg Oncol 38:170-5. 2012
    ..To determine the prognosis of and prognostic factors for mesenteric node involvement in patients undergoing a bowel resection at the time of debulking surgery for primary treatment of advanced-stage ovarian cancer (ASOC)...
  43. ncbi request reprint [Concomitant radiochemotherapy in cancer of the cervix uteri: modifications of the standards]
    C Haie-Meder
    Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France
    Cancer Radiother 4:134s-140s. 2000
    ..Five of the randomized trials evidenced the superiority of cis-platin-based chemotherapy, but the optimal chemotherapeutic regimens remain to be defined...
  44. ncbi request reprint [Prognosis and fertility after conservative treatment for ovarian tumors of limited malignity: review of 68 cases]
    S Camatte
    Service de chirurgie oncologique gynécologique, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France
    Gynecol Obstet Fertil 30:583-91. 2002
    ..The aim of this retrospective study was to evaluate the rate of recurrence and the reproductive outcome after surgical conservative treatment of low malignant ovarian tumors (LMOT)...
  45. doi request reprint Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor
    T de La Motte Rouge
    Department of Medical Oncology, Institut Gustave Roussy, Villejuif
    Ann Oncol 19:1435-41. 2008
    ..Current treatment consists of surgery followed by bleomycin, etoposide, and cisplatin (BEP) chemotherapy. However, given the rarity of this tumor, ovarian YST-specific survival and outcome after such treatment are not precisely known...
  46. doi request reprint [First line chemotherapy of advanced epithelial ovarian cancer]
    C Lhomme
    Institut Gustave Roussy, Comité de gynécologie, 39 rue Camille Desmoulins, 94805 Villejuif, France
    Bull Cancer 96:1207-13. 2009
    ..As for numerous cancerous pathologies, the targeted therapies, notably the antiangiogenic one, represent an important hope in the treatment of the ovarian cancer...
  47. doi request reprint [Para-aortic lymphadenectomy in advanced-stage cervical cancer: standard procedure in 2010?]
    C Uzan
    Departement de Chirurgie, Institut Gustave Roussy, 114, rue Edouard Vaillant, 94805 Villejuif Cedex, France
    Gynecol Obstet Fertil 38:668-71. 2010
    ..Radiotherapy progress, especially with boost and combination to MRI (MRIT), will impact on future therapeutic management...
  48. doi request reprint [Survival and prognostic factors after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer]
    C Touboul
    Département de chirurgie gynécologique, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
    Gynecol Obstet Fertil 39:274-80. 2011
    ..The aim of this study was to evaluate the prognostic factors of patients undergoing completion surgery for locally advanced-stage cervical cancer after initial chemoradiation therapy (CRT)...
  49. doi request reprint [Laparoscopic radical hysterectomy after initial brachytherapy for stage IB1 cervical cancer: feasibility and results]
    C Uzan
    Departement de Chirurgie, Universite Paris Sud, Institut Gustave Roussy, 94800 Villejuif, France Unité Inserm U 1030, Institut Gustave Roussy, 94800 Villejuif, France Electronic address
    Gynecol Obstet Fertil 41:571-7. 2013
    ..The aim of this study was to examine the feasibility and to report the results of laparoscopic radical hysterectomy (LRH) after initial uterovaginal brachytherapy (BT) for stage IB1 cervical cancer...
  50. doi request reprint [Outcome of cervical carcinoma with locoregional lymph node involvement by FDG-PET]
    A Paumier
    Departement de Radiotherapie, Institut de Cancerologie Gustave Roussy, Villejuif, France
    Cancer Radiother 16:183-9. 2012
    ..To assess the outcome of cervical carcinoma with positive nodes on fluorodesoxyglucose positon emission tomography scans (FDG-PET)...
  51. ncbi request reprint Clinical outcome after laparoscopic pure management of borderline ovarian tumors: results of a series of 34 patients
    S Camatte
    Institut Gustave Roussy, Villejuif, France
    Ann Oncol 15:605-9. 2004
    ..The aim of this study was to assess clinical outcome after laparoscopic treatment of borderline ovarian tumor (BOT)...
  52. ncbi request reprint [Laparoscopic treatment of borderline ovarian tumor: analysis of 54 patients and clinical outcomes]
    S Camatte
    Service de Chirurgie, Institut Gustave Roussy, Villejuif, France
    Gynecol Obstet Fertil 33:395-402. 2005
    ..The aim of this study is to assess the clinical outcomes of laparoscopic treatment of borderline ovarian tumor (BOT)...
  53. doi request reprint [Laparoscopic para-aortic lymphadenectomy in advanced cervical cancer: morbidity and impact on therapy]
    A Souadka
    Departement de Chirurgie, Institut Gustave Roussy, 114 rue Edouard Vaillant, Villejuif, France
    Gynecol Obstet Fertil 40:153-7. 2012
    ..This study aimed to define clinical implications, review complications, and determine whether surgical complications delayed the start of CRT...
  54. ncbi request reprint Cisplatin-based chemotherapy regimen (DECAV) for uterine sarcomas
    P Pautier
    Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France
    Int J Gynecol Cancer 12:749-54. 2002
    ..Median overall survival was 14 month overall, 45 months for Group 1 and 13 months for Group 2. We conclude that the DECAV regimen is clearly active in uterine sarcomas but is too toxic to be recommended routinely...
  55. ncbi request reprint [Does adenocarcinoma of uterine cervix have a worse prognosis than squamous carcinoma?]
    A Recoules-Arche
    Service de chirurgie oncologique gynécologique, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
    Gynecol Obstet Fertil 32:116-21. 2004
    ..The objective of this study was to examine the influence of histology on the outcome of patients with cervix carcinoma, treated with radiotherapy and radical surgery...
  56. ncbi request reprint Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity
    Yann Delpech
    Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805, Villejuif, France
    Ann Surg Oncol 14:3223-31. 2007
    ..The aim of this study was twofold: to evaluate the rate of histological PA+ after PCRT and to determine the survival of patients with PA+...
  57. doi request reprint Outcome of patients with incomplete resection after surgery for stage IB2/II cervical carcinoma with chemoradiation therapy
    Catherine Uzan
    Department of Surgery, Institut Gustave Roussy and University Paris Sud
    Int J Gynecol Cancer 20:379-84. 2010
    ..There is no standard management when surgical resection is incomplete. The aim of this study was to describe the outcome of these patients...
  58. ncbi request reprint [Clinical practice guidelines: 2006 update of recommendations for the radiotherapeutic management of patients with soft tissue sarcoma (sarcoma of the extremity, uterine sarcoma and retroperitoneal sarcoma]
    C Le Pechoux
    Institut Gustave Roussy, Villejuif, France
    Cancer Radiother 10:185-207. 2006
    ..This work is based on the methodology developed in the "Standards, Options and Recommendations" (SOR) project...
  59. ncbi request reprint CT findings in two cases of port-site metastasis after laparoscopy for ovarian cancer
    J Viala
    Department of Radiology, Institut Gustave Roussy, Villejuif, France
    Eur J Gynaecol Oncol 23:293-4. 2002
    ..In both patients, CT scan revealed the presence of an heterogeneous nodular lesion inside the left oblique muscle. Histologic analysis confirmed the diagnosis of port-site recurrence...
  60. ncbi request reprint Case 2. Spontaneous regression of peritoneal implants in borderline ovarian tumor after salpingo-oophorectomy
    P Morice
    Institut Gustave Roussy, Villejuif, France
    J Clin Oncol 21:3536-8. 2003
  61. ncbi request reprint Laparoscopic total pelvic exenteration for cervical cancer relapse
    C Pomel
    Department of Surgical Oncology, Gustave Roussy Institute Comprehensive Cancer Centre, 39, rue Camille Desmoulins, 94805, Villejuif, France
    Gynecol Oncol 91:616-8. 2003
    ..Laparoscopy classically reduces morbidity and invasiveness. To decrease the operative morbidity associated with exenteration, we considered the possibility of performing a total pelvic exenteration by the laparoscopic approach...
  62. ncbi request reprint Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma
    S Muschitz
    Brachytherapy Unit, Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France
    Radiother Oncol 73:187-94. 2004
    ..This study correlates the treated volume, the GTV and the CTV at the time of intracavitary brachytherapy (BT) with the histopathological findings obtained by surgery (S) in 33 patients (pts) with cervix carcinoma...
  63. ncbi request reprint [Should we put an end to systematic lomboaortic lymphadenectomy in ovarian cancer?]
    P Morice
    Service de Chirurgie, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805, Villejuif Cedex, France
    Gynecol Obstet Fertil 35:1167-9. 2007
  64. doi request reprint Results after conservative treatment of serous borderline tumours of the ovary with stromal microinvasion but without micropapillary pattern
    I Laurent
    Department of Surgery, Institut Gustave Roussy, Villejuif, France
    BJOG 116:860-2. 2009
    ..All women are currently disease free. Three women achieved a spontaneous pregnancy and three became pregnant after an in vitro fertilisation procedure. This study suggests that conservative treatment of SBOT-SMI is safe...
  65. doi request reprint How to follow up advanced-stage borderline tumours? Mode of diagnosis of recurrence in a large series stage II-III serous borderline tumours of the ovary
    C Uzan
    Department of Gynecologic Surgery, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
    Ann Oncol 22:631-5. 2011
    ..The aim of this study was to describe how recurrences were diagnosed in the largest series of patients treated for an advanced-stage serous borderline ovarian tumour...
  66. doi request reprint Feasibility of ovarian cryopreservation in borderline ovarian tumours
    V Fain-Kahn
    Institut Gustave Roussy, Villejuif 94805, France
    Hum Reprod 24:850-5. 2009
    ..BOT also arise in younger patients than those who develop epithelial ovarian tumours. Our aim was to evaluate the feasibility of ovarian cryopreservation (OC) in patients treated for BOT...
  67. doi request reprint [Is radical surgery (or parametrectomy) needed in all surgical procedure for early stage cervical cancer?]
    C Uzan
    Departement de Chirurgie, Institut Gustave Roussy, 39, 94805 Villejuif Cedex, France
    Gynecol Obstet Fertil 37:504-9. 2009
    ..This review reports studies exploring the safety of omitting parametrectomy in these low risk patients and the future possibilities to evaluate these new indications...
  68. doi request reprint Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary
    C Uzan
    Department of Gynecologic Surgery, Institut Gustave Roussy, Villejuif, France
    Ann Oncol 21:55-60. 2010
    ..The aim of this study was to assess the outcomes of the largest series of patients treated conservatively for a stage II or III serous borderline ovarian tumor...
  69. doi request reprint [The accuracy of FDG-PET/CT in early-stage cervical and vaginal cancers]
    E Bentivegna
    Departement de Chirurgie, Institut Gustave Roussy, Universite Paris Sud, Villejuif, France
    Gynecol Obstet Fertil 39:193-7. 2011
    ..The aim of this study was to evaluate false negative rate of FDG-PET/CT in early-stage cervical and vaginal cancer...
  70. ncbi request reprint Prognostic significance of epithelial disorders adjacent to invasive vulvar carcinomas
    R Rouzier
    Department of Gynecologic Surgery, Institut Gustave Roussy, 39 rue Camille Desmoulins, Villejuif Cedex, 94805, France
    Gynecol Oncol 81:414-9. 2001
    ..CONCLUSION: The results of this study support the view that histological evidence of epithelial alterations adjacent to invasive carcinoma can serve to separate patients that differ in terms of prognosis...
  71. ncbi request reprint Management and clinical outcomes of pregnant patients with invasive cervical cancer
    N Germann
    Department of radiothérapie, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94 805 Villejuif, France
    Ann Oncol 16:397-402. 2005
    ..The objective of this study was to evaluate the clinical outcomes and to discuss the management of women presenting with an invasive cervical cancer during pregnancy...
  72. doi request reprint [Adjuvant therapy and role of radiation therapy in advanced endometrial cancers]
    C Haie-Meder
    Service de curiethérapie, Institut Gustave Roussy, rue Camille Desmoulins, 94800 Villejuif, France
    Cancer Radiother 12:630-2. 2008
    ..Despite these advances, numerous questions remain on the best therapeutic sequence. Optimal chemotherapy regimens remain to be determined. On-going randomized trials will help to answer these questions...
  73. ncbi request reprint Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma
    Elie Azria
    Department of Surgery, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805, Villejuif, France
    Ann Surg Oncol 12:332-7. 2005
    ..We assessed the clinical outcome after hysterectomy in patients with bulky residual disease after chemoradiotherapy for stage IB2/II cervical carcinoma...
  74. doi request reprint Secondary surgery in patients with serous low malignant potential ovarian tumors with peritoneal implants
    Aminata Kane
    Department of Gynecologic Surgery, Institut Gustave Roussy, Villejuif, France
    Int J Gynecol Cancer 20:346-52. 2010
    ..To determine the impact of secondary surgery in patients treated for a serous low malignant potential ovarian tumor (LMPOT) and peritoneal implants...
  75. ncbi request reprint Should pelvic and para-aortic lymphadenectomy be different depending on histological subtype in epithelial ovarian cancer?
    Natacha Roger
    Service de Chirurgie, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805, Villejuif, France
    Ann Surg Oncol 15:333-8. 2008
    ....
  76. doi request reprint Surgical procedures and morbidities of diaphragmatic surgery in patients undergoing initial or interval debulking surgery for advanced-stage ovarian cancer
    Sebastien Gouy
    Institut Gustave Roussy, Villejuif, France
    J Am Coll Surg 210:509-14. 2010
    ..The aim of this study was to evaluate modalities and morbidities of DS at the time of initial surgery (INS) and interval debulking surgery (IDS; performed after neoadjuvant chemotherapy)...
  77. ncbi request reprint Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes
    Catherine Uzan
    Department of Surgery, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
    Ann Surg Oncol 11:658-64. 2004
    ..The aim was to study the prognosis for and survival of patients treated with combined therapy (including surgical resection) for nodal recurrences from epithelial ovarian cancer (EOC)...
  78. ncbi request reprint Lymph node spread in stage III or IV primary peritoneal serous papillary carcinoma
    Gil Dubernard
    Service de Chirurgie, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
    Gynecol Oncol 97:136-41. 2005
    ..The aim of this study was to determine the rates and topography of pelvic and para-aortic nodal involvement in patients with stage III or IV primary peritoneal serous papillary carcinoma (PSPC)...
  79. ncbi request reprint Exclusive radiotherapy for primary squamous cell carcinoma of the vagina
    Renaud de Crevoisier
    Department of Radiation Oncology, Institut Gustave Roussy, 39 rue Camille Desmoulins, Villejuif, France
    Radiother Oncol 85:362-70. 2007
    ..To retrospectively analyze results of external beam therapy (EBT) with brachytherapy (BT) for primary vaginal squamous cell carcinoma (PVSCC)...
  80. doi request reprint Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area
    Mathias Boughanim
    Department of Surgery, Institut Gustave Roussy, and University Paris Sud, Villejuif, France
    J Clin Oncol 26:2558-61. 2008
    ....
  81. doi request reprint Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy : correlation of radiologic findings with surgicopathologic results
    Etienne Vincens
    Department of Surgery, Gustave Roussy Institute and South Paris University, Villejuif, France
    Cancer 113:2158-65. 2008
    ..Very few studies have correlated MRI and histologic findings specifically in cervix cancer. This was the objective of the current study...
  82. ncbi request reprint Are serum inhibin concentrations new markers of placental tumours in the course of chemotherapy?
    P Pautier
    Medical Department, Gynecological Unit, Institut Gustave Roussy, 94805 Villejuif, France
    Hum Reprod 16:2434-7. 2001
    ..The study was conducted to evaluate whether the detection of serum molecular forms of inhibin (A and B) could be useful for the diagnosis, prognosis and follow-up of placental tumours...
  83. ncbi request reprint [Endometrial surveillance of women on tamoxifen]
    C Lhomme
    Comité de gynécologie, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94800 Villejuif, France
    Gynecol Obstet Fertil 31:647-56. 2003
    ..Besides, it is absolutely necessary to recommend them to take quickly medical advice in case of gynecologic symptoms...
  84. ncbi request reprint [Cancer and pregnancy: the medical oncologist's point of view]
    P Pautier
    Service de Gynecologie, Institut Gustave Roussy, Villejuif
    J Gynecol Obstet Biol Reprod (Paris) 33:S23-8. 2004
    ..The long-term risks of cancer on the mother's subsequent fertility or the child's intellectual development are not well-known. Such factors must be examined in prospective studies and registered in a specific database...
  85. ncbi request reprint Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type
    P Pautier
    Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France
    Ann Oncol 18:1985-9. 2007
    ..The evaluation of first-line intensive combination therapy in small cell carcinoma of the ovary (SCCO)...
  86. doi request reprint [Implementation of GEC-ESTRO recommendations on 3-D based image brachytherapy]
    C Haie-Meder
    Service de curiethérapie, Institut Gustave Roussy, rue Camille Desmoulins, 94800 Villejuif, France
    Cancer Radiother 12:522-6. 2008
    ..The sigmoid is currently under study as this organ was not extensively studied before the era of imaging. Doses to the tumour (HR-CTV or IR-CTV) are not clearly stated and will likely depend on tumour extension...
  87. doi request reprint [Three-dimensional brachytherapy optimization techniques in the treatment of patients with cervix cancer]
    C Haie-Meder
    Service de curiethérapie, Institut Gustave Roussy, 94800 Villejuif, France
    Cancer Radiother 13:520-4. 2009
    ..Further studies are needed to better define the dose recommended in both tumour and organs at risk. This is one of the goals of the European study on MRI-guided brachytherapy in locally advanced cervical cancer (EMBRACE) protocol...
  88. ncbi request reprint [Cancer and pregnancy: the point of view of the chemotherapy oncologist]
    Patricia Pautier
    Comité de gynécologie, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif
    Bull Cancer 89:779-85. 2002
    ..Regarding the long term risks of cancer on fertility or child's intellectual development, they are still not well known and must be included into prospective studies, as well as being registered in a specific data file...
  89. ncbi request reprint [HIV and uterine cervical cancer]
    Patricia Pautier
    Oncolague médical, Comité de gynécologie, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif
    Bull Cancer 90:399-404. 2003
    ..Antiviral treatment and infectious prophylaxis have to be reinforced. A special care will be required for radiotherapy technical execution and clinical (digestive) and hematological follow-up through out the treatment...
  90. ncbi request reprint Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer
    Philippe Morice
    Department of Surgery, Institut Gustave Roussy, Villejuif, France
    J Am Coll Surg 197:955-63. 2003
    ..Results of IDS (after three to four courses of induction chemotherapy) were compared with PDS followed by chemotherapy in patients treated for advanced stage ovarian cancer (stage IIIC or IV)...
  91. ncbi request reprint Laparoscopic radical hysterectomy for invasive cervical cancer: 8-year experience of a pilot study
    Christophe Pomel
    Department of Surgical Oncology, Institut Gustave Roussy Comprehensive Cancer Centre, Villejuif 94805, France
    Gynecol Oncol 91:534-9. 2003
    ..The aim of this study was to retrospectively evaluate, in a series of 50 consecutive patients, the feasibility, morbidity, and survival outcome of the laparoscopic radical hysterectomy for carcinoma of the uterine cervix...
  92. ncbi request reprint Anatomy of pelvic and para-aortic nodal spread in patients with primary fallopian tube carcinoma
    Xavier Deffieux
    Department of Gynecological Surgery, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
    J Am Coll Surg 200:45-8. 2005
    ..To describe characteristics of patients with nodal spread and the anatomy of pelvic and para-aortic node involvement in primary fallopian tube carcinoma...
  93. ncbi request reprint Results after laparoscopic management of serous borderline tumor of the ovary with peritoneal implants
    Xavier Deffieux
    Service de Chirurgie Gynecologique, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
    Gynecol Oncol 97:84-9. 2005
    ..The aim of this study is to assess the clinical outcomes of laparoscopic treatment of borderline ovarian tumor (BOT) with peritoneal implants...
  94. ncbi request reprint [Concomitant chemoradiation in patients with cervix cancer]
    Christine Haie-Meder
    Service de curiethérapie, Departement de Radiotherapie, Institut Gustave Roussy, rue Camille Desmoulins, 94800 Villejuif
    Bull Cancer 92:1032-8. 2005
    ..Future randomised trials should also aim to establish optimal chemotherapy regimens for combination with radiotherapy...
  95. ncbi request reprint Prognosis of patients who relapse after fertility-sparing surgery in epithelial ovarian cancer
    Olivier Marpeau
    Institut Gustave Roussy, 39 rue Camille Desmoulins, Villejuif, France
    Ann Surg Oncol 15:478-83. 2008
    ..This is the first study to evaluate survival in patients who have developed a recurrence in this context...
  96. doi request reprint Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern
    Isabelle Laurent
    Service de Chirurgie Gynecologique, Institut Gustave Roussy, Villejuif Cedex, France
    Ann Surg Oncol 15:3561-6. 2008
    ..The aim of this study was to assess the outcomes of patients treated conservatively for a serous borderline ovarian tumor with micropapillary patterns (SBOT-MP)...
  97. doi request reprint [Clinical practice guidelines 2008 for the surgical treatment, medical first-line and consolidation treatments of patients with epithelial ovarian cancer--update. According to the methodology of Standards, Options: Recommendations (SOR)]
    Catherine Lhomme
    Institut Gustave Roussy, 94805 Villejuif, France
    Bull Cancer 95:881-6. 2008
    ..Following the monitoring process, we identified new data conferring sufficient elements to justify an updating of the CPG concerning the surgical, the medical fi rst-line and consolidation treatments of epithelial ovarian cancers...
  98. doi request reprint DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery
    Christine Haie-Meder
    Department of Radiotherapy Brachytherapy Service, Institut Gustave Roussy, Villejuif, France
    Radiother Oncol 93:316-21. 2009
    ..To our knowledge no DVH data have so far been reported for MRI-guided BT in the preoperative setting of early-stage cervical cancer. We assessed DVH parameters and clinical outcome using 3D MRI-guided preoperative intracavitary LDR BT...
  99. doi request reprint MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy
    Christine Haie-Meder
    Department of Radiotherapy Brachytherapy Service, Institut Gustave Roussy, Villejuif, France
    Radiother Oncol 96:161-5. 2010
    ..To retrospectively assess the physics contributions and the clinical outcome with preliminary 3D MRI-guided low dose-rate (LDR) intracavitary brachytherapy (BT) experience in locally advanced cervical cancer patients...
  100. ncbi request reprint [Effects of radiotherapy (external and/or internal) and chemotherapy on female fertility]
    Philippe Morice
    Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
    Bull Acad Natl Med 194:481-92; discussion 492-4, 529-30. 2010
    ..Both external and internal radiation has an impact on the uterus, notably by altering its vascularization and by reducing its growth when treatment is delivered during childhood...
  101. pmc Low-dose-rate definitive brachytherapy for high-grade vaginal intraepithelial neoplasia
    Pierre Blanchard
    Radiation Oncology Department, Brachytherapy Unit, Gustave Roussy Institute, 114 rue Edouard Vaillant, 94805 Villejuif, France
    Oncologist 16:182-8. 2011
    ..We report the results of low-dose-rate (LDR) vaginal brachytherapy for grade 3 VAIN (VAIN-3) over a 25-year period at Gustave Roussy Institute...